share_log

Xilio Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Gilead Sciences, Inc.(19.9%)

Xilio Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals

Xilio Therapeutics | SC 13G:超过5%持股股东披露文件
SEC announcement ·  04/05 16:36
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息